Lerapolturev Not Yet Recruiting Phase 2 Trials for Recurrent Supratentorial Glioblastoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT06177964Lerapolturev (PVSRIPO) in GBM